Moxestrol
Clinical data | |
---|---|
Trade names | Surestryl |
Other names | R-2858, RU-2858, NSC-118191; 11β-Methoxy-17α-ethynylestradiol; 11β-MeO-EE 11β-Methoxy-17α-ethynylestra-1,3,5(10)-triene-3,17β-diol |
Pregnancy category |
|
Estrogen ether | |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | 33%[1] |
Protein binding | Minimal[1] |
Metabolism | Liver[2] |
Elimination half-life | 8.2 hours[1] |
Identifiers | |
| |
JSmol) | |
| |
|
Moxestrol, sold under the brand name Surestryl, is an
Medical uses
Moxestrol is or has been used in the treatment of
menopausal symptoms and menstrual disorders.[2][6] It has been used at dosages of 50 to 150 µg per week for long-term therapy to 25 to 250 µg per day for short-term therapy.[6]
Pharmacology
Pharmacodynamics
Moxestrol is an
sex hormone binding globulin and low binding to serum albumin,[1] and its lower relative rate of metabolism.[2][5] In contrast to estradiol, which has roughly the same affinity for both ERs (Ki = 0.12 nM and 0.15 nM, respectively), moxestrol possesses several-fold selectivity for the ERα (Ki = 0.50 nM) over ERβ (Ki = 2.6 nM).[8]
Compound | PR | AR | ER | GR | MR | SHBG | CBG
|
---|---|---|---|---|---|---|---|
Estradiol | 2.6 | 7.9 | 100 | 0.6 | 0.13 | 8.7 | <0.1 |
Ethinylestradiol | 15–25 | 1–3 | 112 | 1–3 | <1 | ? | ? |
Moxestrol (11β-MeO-EE) | 0.8 | <0.1 | 12 | 3.2 | <0.1 | <0.2 | <0.1 |
RU-16117 (11α-MeO-EE) | 1–3 | <1 | 13 | <1 | <1 | ? | ? |
Notes: Values are percentages (%). Reference . Sources: |
Pharmacokinetics
The bioavailability of moxestrol is 33%.[1] Its plasma protein binding is minimal.[1] The medication is metabolized in the liver.[2] Its biological half-life is 8.2 hours.[1]
Chemistry
Moxestrol, also known as 11β-methoxy-17α-ethynylestradiol (11β-MeO-EE) or as 11β-methoxy-17α-ethynylestra-1,3,5(10)-triene-3,17β-diol, is a
11β-methoxyestradiol with an ethynyl group at the C17α position.[3] The compound is the C11β isomer or C11 epimer of RU-16117 (11α-methoxy-17α-ethynylestradiol.[13]
Society and culture
Generic names
Moxestrol is the
.Brand names
Moxestrol is or has been marketed under the brand name Surestryl.[3][4]
Availability
Moxestrol is or has been marketed in Europe.[2]
References
- ^ PMID 6887930.
- ^ ISBN 978-1-4613-9208-8.
- ^ ISBN 978-1-4757-2085-3.
- ^ ISBN 978-0-7514-0499-9.
- ^ ISBN 978-0-8247-8624-3.
- ^ ISBN 978-0-85369-300-0.
Moxestrol is a synthetic oestrogen with actions and uses similar to thosre described for the oestrogens in general. Moxestrol is reponed to have a prolonged duration of action. It has been given by mouth in the treatment of menopausal, postmenopausal, and menstrual symptoms. Dose have ranged from 50 to 100 µg weekly for long-term therapy to 25 to 250 µg daily for short-term use.
- PMID 679210.
- PMID 16452668.
- ISBN 9781483216102.
- PMID 359134.
- PMID 3695484.
- PMID 7421203.
- ISBN 978-1-4831-5308-7.